glp 1 receptor agonists beyond their pancreatic effects Risk of cancer associated with GLP-1 agonist therapy GLP1-GIP receptor co-agonists: a promising
Description
BMC Ophthalmol
2018;10 doi: 10.7759/cureus.3791
Basic science and clinical research evidence indicates that GLP-1RAs produce direct immunomodulatory actions that function separately from weight loss
Investigation 79 (2), 616619
